FRANKLIN LAKES, N.J. & ASHLAND, Ore.--(BUSINESS WIRE)--FlowJo, LLC, the provider of the market-leading third-party software for single cell analysis, and BD Life Sciences – Biosciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), announced today that they have established a strategic relationship to integrate BD’s flow cytometry data acquisition software with FlowJo’s data analysis platform for the research market.
The integrated software would enable upload of acquired data from BD flow cytometers running BD FACSDiva™ software directly to FlowJo Enterprise, paving the way for user-friendly data management and provenance tracking for researchers using flow cytometry. FlowJo Enterprise will enable researchers to initiate pipelined data analysis directly from the instrument. The direct upload would offer a superior customer and research experience seamlessly linking flow cytometry data acquisition to final results and reports.
“We are very excited to be partnering with an industry leader to enable a single process from acquired data to results,” said Michael Stadnisky PhD, CEO of FlowJo. “Two powerful tools are now united to better serve researchers and transform curiosity into discovery.”
FlowJo and BD demonstrated the integration prototype at CYTO 2015: the 30th Congress of the International Society for Advancement of Cytometry, in Glasgow, Scotland.
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world’s most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of “Helping all people live healthy lives” by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visitwww.bd.com.
FlowJo is a privately owned life sciences software company based in Ashland, Oregon. Based on technology developed at Stanford, the company was founded in 1997 and provides the leading analysis platform for flow and mass cytometry analysis. Their FlowJo Enterprise platform enables discovery, high-throughput analysis, and data leadership in flow and mass cytometry. For more information, see www.FlowJo.com